Drug Delivery Systems Market Report 2025 – Strategic Insights for Growth, Expansion & Competitive Advantage
The Business Research Company's Drug Delivery Systems Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, July 1, 2025 /EINPresswire.com/ -- The unparalleled surge in the drug delivery systems market has coined a new narrative for healthcare growth. This projected increase from $41.17 billion in 2024 to $44.21 billion in 2025, with a compound annual growth rate CAGR of 7.4%, signals noteworthy promises for the future of drug administration and therapeutic outcomes. A proven track record of beneficial trends further supports this rising market, from a robust focus on personalized medicine to an expanding pipeline of complex and sensitive drugs. However, it's important to note the influence of factors such as a rising prevalence of rare and orphan diseases and an increasingly aged population in this development. Now, let's delve deeper.
What Will The Drug Delivery Systems Market Look Like In The Future?
The current strong growth is just the beginning. The drug delivery systems market size is expected to balloon to a staggering $58.64 billion by 2029, expanding at a compound annual growth rate CAGR of 7.3%. A bevy of favorable regulatory pathways for innovative delivery systems, along with the growth of personalized medicine and the increasing demand for non-invasive delivery methods, steer this ascension. Then there are trends such as the development of nanotechnology-based drug delivery systems and advances in biologics and biosimilars requiring specialized delivery. The integration of smart drug delivery devices and advancement of targeted delivery systems for oncology are also pushing the envelope.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp
What's Driving This Phenomenal Growth In The Drug Delivery Systems Market?
Respiratory disorders - a deeply concerning health anomaly worldwide, are anticipated to be potent catalysts fueling the boom of the drug delivery systems market. These health conditions, which include asthma, chronic obstructive pulmonary disease COPD, pulmonary fibrosis, and cystic fibrosis, impair the normal functioning of the lungs and airways. As air pollution escalates, the number of people suffering from these respiratory disorders is also spiraling upwards, leading to an increased demand for drug delivery systems. In fact, a 13% increase in Tuberculosis cases was reported in England in 2024, setting a clear precedent for this trend. As such, the drug delivery system serves as a lifeline in these circumstances by ensuring medications are delivered directly to the lungs, enhancing therapeutic outcomes while minimizing systemic side effects.
Who Are The Worthy Players In The Drug Delivery Systems Market?
Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., and VasoRx Inc are some of the companies that dominate the global drug delivery systems market. These companies have shown remarkable innovation and development in recent times, contributing heavily to the sector's growth.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report
What Are The New Trends In The Drug Delivery Systems Market?
Major companies are now focusing on advanced solutions like metal-free, multidose nasal spray pumps for improved user comfort and ease of handling. With their safety and compatibility benefits, these devices are designed to deliver multiple doses of medication through the nasal passage without any metal components.
How Is The Drug Delivery Systems Market Segmented?
Looking at the drug delivery systems market from a segmentation perspective, the market is divided by type, material, application, and end-user. By type, we have Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System. By material, Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems dominate the market. The segments by application include Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, and Others. The end-user segment consists of Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories.
What Are The Regional Insights In The Drug Delivery Systems Market?
Regionally, North America reigned supreme in the drug delivery systems market in 2024. However, the rapidly evolving healthcare infrastructure in Asia-Pacific makes it the fastest-growing region in the forecast period.
Browse Through More Similar Reports By The Business Research Company:
Advanced Drug Delivery Systems Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report
Pharmaceutical Drug Delivery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Electronic Drug Delivery Systems Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report
About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas - +1 310-496-7795
Asia +44 2071930708
Europe - +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+ +44 7882 955267
info|tbrc.info| |info|tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Fighting the SFTS virus with lipoxygenase: a new hope for treatment
Medical Electronics Market CAGR 6.7% | $23 Billion Revenue by 2032
ProFirst Training and Sandy Police Department Deliver Regional Law Enforcement Background Investigations Training -Utah
Kalendarium
Więcej ważnych informacji
Jedynka Newserii

Jedynka Newserii

Prawo

KE proponuje nowy Fundusz Konkurencyjności. Ma pobudzić inwestycje w strategiczne dla Europy technologie
W środę 16 lipca Komisja Europejska przedstawiła projekt budżetu na lata 2028–2034. Jedna z propozycji zakłada utworzenie Europejskiego Funduszu Konkurencyjności o wartości ponad 400 mld euro, który ma pobudzić inwestycje w technologie strategiczne dla jednolitego rynku. Wśród wspieranych obszarów znalazła się obronność i przestrzeń kosmiczna. Na ten cel ma trafić ponad 130 mld euro, pięciokrotnie więcej niż do tej pory.
Firma
Były prezes PGE: OZE potrzebuje wsparcia magazynów energii. To temat traktowany po macoszemu

Choć udział odnawialnych źródeł energii w miksie energetycznym Polski jest stosunkowo wysoki i rośnie, to ten przyrost jest chaotyczny i nierównomiernie rozłożony miedzy technologiami – wskazuje Forum Energii. Dodatkowo OZE potrzebują wsparcia magazynów energii, a zdaniem Wojciecha Dąbrowskiego, prezesa Fundacji SET, ten temat jest traktowany po macoszemu. Brak magazynów powoduje, że produkcja energii z OZE jest tymczasowo wyłączana, co oznacza marnowanie potencjału tych źródeł.
Infrastruktura
Wzrost wynagrodzeń ekip budowlanych najmocniej wpływa na koszty budowy domu. Zainteresowanie inwestorów mimo to nieznacznie wzrasta

Budowa metra kwadratowego domu w Polsce kosztuje od 5,55 do 6 tys. zł w zależności od województwa – wynika z najnowszych analiz firmy Sekocenbud. Najdrożej jest w Warszawie, gdzie cena za metr kwadratowy domu przekroczyła już 6,2 tys. zł. Na przyrosty kosztów budowy domu wpływają zarówno drożejące materiały budowlane, jak i wyższe wynagrodzenia pracowników. Inwestorzy nie rezygnują jednak z budowy domów jednorodzinnych, co ma związek m.in. z wciąż wysokimi cenami mieszkań czy też obniżką stóp procentowych.
Partner serwisu
Szkolenia

Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.